This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
S$0.03858
Share price
0.00%
Change (1 day)
-95.13%
Change (1 year)
Categories
Advaxis (ADXS) - Net assets
Net assets on the balance sheet as of December 2023 : -S$31.41 Million
According to Advaxis's latest financial reports the company has -S$31.41 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Advaxis - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-S$32.25 Million | 2088.77% |
| 2022-12-31 | $-S$1.48 Million | -103.19% |
| 2021-12-31 | $S$46.17 M | -9.09% |
| 2020-12-31 | $S$50.79 M | -196.81% |
| 2019-12-31 | $-S$52.48 Million | 75.71% |
| 2018-12-31 | $-S$29.87 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Inovio Pharmaceuticals INO | S$65.91 M | -309.90% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | S$15.92 M | -150.72% | 🇺🇸 USA |
 Heska Corporation
HSKA | S$0.53 B | -1,810.57% | 🇺🇸 USA |